290 related articles for article (PubMed ID: 31562134)
21.
Maura F; Dodero A; Carniti C; Bolli N; Magni M; Monti V; Cabras A; Leongamornlert D; Abascal F; Diamond B; Rodriguez-Martin B; Zamora J; Butler A; Martincorena I; Tubio JMC; Campbell PJ; Chiappella A; Pruneri G; Corradini P
Haematologica; 2021 Nov; 106(11):2918-2926. PubMed ID: 33054126
[TBL] [Abstract][Full Text] [Related]
22. Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.
Asano N; Suzuki R; Ohshima K; Kagami Y; Ishida F; Yoshino T; Ogawa H; Morishima Y; Nakamura S
Int J Hematol; 2010 Apr; 91(3):426-35. PubMed ID: 20217288
[TBL] [Abstract][Full Text] [Related]
23. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
[TBL] [Abstract][Full Text] [Related]
24. The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS).
Zhang Y; Wang G; Zhao X; Hu Y; Tan Su Yin E; Chen D; Wang H; Zhao K
BMC Med Imaging; 2021 Oct; 21(1):145. PubMed ID: 34627196
[TBL] [Abstract][Full Text] [Related]
25. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.
Valleron W; Ysebaert L; Berquet L; Fataccioli V; Quelen C; Martin A; Parrens M; Lamant L; de Leval L; Gisselbrecht C; Gaulard P; Brousset P
Blood; 2012 Nov; 120(19):3997-4005. PubMed ID: 22990019
[TBL] [Abstract][Full Text] [Related]
26. Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.
Watatani Y; Sato Y; Miyoshi H; Sakamoto K; Nishida K; Gion Y; Nagata Y; Shiraishi Y; Chiba K; Tanaka H; Zhao L; Ochi Y; Takeuchi Y; Takeda J; Ueno H; Kogure Y; Shiozawa Y; Kakiuchi N; Yoshizato T; Nakagawa MM; Nanya Y; Yoshida K; Makishima H; Sanada M; Sakata-Yanagimoto M; Chiba S; Matsuoka R; Noguchi M; Hiramoto N; Ishikawa T; Kitagawa J; Nakamura N; Tsurumi H; Miyazaki T; Kito Y; Miyano S; Shimoda K; Takeuchi K; Ohshima K; Yoshino T; Ogawa S; Kataoka K
Leukemia; 2019 Dec; 33(12):2867-2883. PubMed ID: 31092896
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified.
Kim HD; Cho H; Sohn BS; Park CS; Huh J; Ryu JS; Lee SW; Yoon SE; Kim SJ; Ko YH; Kim WS; Suh C
Leuk Lymphoma; 2022 Jan; 63(1):124-130. PubMed ID: 34702115
[TBL] [Abstract][Full Text] [Related]
28. Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS.
Sugio T; Miyawaki K; Kato K; Sasaki K; Yamada K; Iqbal J; Miyamoto T; Ohshima K; Maeda T; Miyoshi H; Akashi K
Blood Adv; 2018 Sep; 2(17):2242-2252. PubMed ID: 30194138
[TBL] [Abstract][Full Text] [Related]
29. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
Rüdiger T; Weisenburger DD; Anderson JR; Armitage JO; Diebold J; MacLennan KA; Nathwani BN; Ullrich F; Müller-Hermelink HK;
Ann Oncol; 2002 Jan; 13(1):140-9. PubMed ID: 11863096
[TBL] [Abstract][Full Text] [Related]
30. Genomics of Peripheral T-Cell Lymphoma and Its Implications for Personalized Medicine.
Zhang Y; Lee D; Brimer T; Hussaini M; Sokol L
Front Oncol; 2020; 10():898. PubMed ID: 32637355
[TBL] [Abstract][Full Text] [Related]
31. Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients.
Xu P; Yu D; Wang L; Shen Y; Shen Z; Zhao W
Ann Hematol; 2015 Feb; 94(2):239-47. PubMed ID: 25193354
[TBL] [Abstract][Full Text] [Related]
32. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
[TBL] [Abstract][Full Text] [Related]
33. [T-bet in peripheral T-cell lymphoma].
Wang Z; Zhang DB; Zhou W
Zhonghua Xue Ye Xue Za Zhi; 2016 Sep; 37(9):779-783. PubMed ID: 27719721
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
Hsi ED; Horwitz SM; Carson KR; Pinter-Brown LC; Rosen ST; Pro B; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Collie AM; Gruver AM; Grzywacz BJ; Turakhia S; Shustov AR; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Park SI; Foss FM
Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):193-200. PubMed ID: 28209473
[TBL] [Abstract][Full Text] [Related]
35. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
[TBL] [Abstract][Full Text] [Related]
36. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
[TBL] [Abstract][Full Text] [Related]
37. [Expression profiling of microRNA and their target genes in peripheral T cell lymphoma, not otherwise specified].
Li M; Lü N; Liu HX; Chen DB; Zhang JZ
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):519-24. PubMed ID: 24246916
[TBL] [Abstract][Full Text] [Related]
38. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.
Armitage JO
Am J Hematol; 2012 May; 87(5):511-9. PubMed ID: 22508369
[TBL] [Abstract][Full Text] [Related]
39. Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
Oluwasanjo A; Kartan S; Johnson W; Alpdogan O; Gru A; Mishra A; Haverkos BM; Gong J; Porcu P
Cancer Treat Res; 2019; 176():83-98. PubMed ID: 30596214
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological analysis of immunohistochemical expression of retinoic acid-related orphan receptor-γt in peripheral T-cell lymphoma, not otherwise specified.
Yanagida E; Miyoshi H; Kawamoto K; Nakashima K; Matsuda K; Yamada K; Muto R; Nagafuji K; Seto M; Ohshima K
Hum Pathol; 2018 Sep; 79():86-92. PubMed ID: 29775622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
